Combined General Shareholder Meeting of May 4, 2012
? Shareholder approval of the corporate and
consolidated financial statements for 2011
? Dividend of ?2.65 per share payable as of May 15,
? Nomination of a new director
? Partial renewal of the Board of Directors
Paris, France - May 4, 2012 - Sanofi (EURONEXT : SAN et
NYSE : SNY) announced its Combined General Shareholder
Meeting was held today at the Palais des Congrès in Paris.
All resolutions were adopted by its shareholders.
During the meeting, shareholders approved, among other
resolutions, the corporate and consolidated financial
statements for the year 2011. At the General Meeting,
shareholders decided the distribution of a dividend in the
amount of ?2.65 per share that will be detached on Euronext
Paris on May 10, 2012 with payment as of May 15, 2012.
The General Meeting also approved the appointment of Mr.
Laurent Attal as a director for a term of four years, i.e.,
until the General Meeting called to approve the financial
statements for the year
2015. Finally, Mr. Uwe Bicker, Mr. Jean-René Fourtou, Ms.
Claudie Haigneré, Ms. Carole Piwnica and Mr. Klaus Pohle have
each been reappointed for a term of four years.
After the Shareholder Meeting, the Board of Directors is
comprised as follows:
? Serge Weinberg, Chairman of the Board of
? Christopher Viehbacher, Chief Executive
? Laurent Attal
? Uwe Bicker
? Robert Castaigne
? Thierry Desmarest
? Lord Douro
? Jean-René Fourtou
? Claudie Haigneré
? Igor Landau
? Suet-Fern Lee
? Christian Mulliez
? Carole Piwnica
? Klaus Pohle
? Gérard Van Kemmel
During the meeting, the shareholders approved the appointment
of statutory and deputy auditors. The shareholders
additionally ratified the move of the registered headquarters
of Sanofi to 54, rue La Boétie, 75008 Paris. During the Board
of Directors session following the meeting, Mr. Klaus Pohle
was renewed as Chairman of the Audit Committee.
The voting results will be available on the company's website
(www.sanofi.com) in the coming days.
The audiocast of the Combined General Shareholder Meeting is
available on the Company's website
Sanofi, a global and diversified healthcare leader,
discovers, develops and distributes therapeutic solutions
focused on patients' needs. Sanofi has core strengths in the
field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, consumer
healthcare, emerging markets, animal health and the new
Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New
York (NYSE: SNY).
Media Relations Investor Relations
Jean-Marc Podvin Sébastien Martel
+ (33) 1 53 77 46 46 + (33) 1 53 77 45 45 [email protected]